SVP, Commercial Strategy

Chief Technical Officer

AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO

Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition

Akero Therapeutics Insider Sold Shares Worth $1,374,665, According to a Recent SEC Filing

Akero Therapeutics Executives Sell Shares to Cover Tax Obligations

Vice President, Supply Chain

Akero Therapeutics is a clinical stage biopharmaceutical company focused on developing transformational treatments for patients with serious metabolic diseases. The Vice President of Supply Chain will lead clinical and commercial supply chain activities, including demand planning, supplier relationship management, and distribution, while collaborating closely with the Technical Operations leadership team.

Sign up with Google

Sign in with Google